The largest database of trusted experimental protocols

Waters acquity uplc system

Manufactured by Waters Corporation
Sourced in United States, United Kingdom, Germany

The Waters Acquity UPLC system is an ultra-performance liquid chromatography (UPLC) instrument designed for high-throughput and high-resolution separation of complex samples. The system utilizes advanced technology to deliver rapid, efficient, and reproducible chromatographic separations. It is capable of operating at high pressures, enabling the use of smaller particle size columns for improved resolution and reduced analysis times.

Automatically generated - may contain errors

131 protocols using waters acquity uplc system

1

UHPLC-MS/MS Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Waters ACQUITY UPLCTM system (Waters, Milford, MA, USA) connected to a hybrid linear ion trap triple-quadrupole mass spectrometer (API 4000 QTRAP™ MS/MS system from AB Sciex, Concord, ON, Canada) via an electrospray (Turbo V) ion source was used in UHPLC-MS/MS analysis. The Waters ACQUITY UPLCTM system was equipped with a binary solvent manager, sample manager, column oven and photodiode array detector (PDA). The control of LC-MS/MS system, data acquisition and processing was done by Analyst software (version 1.5.1, AB Sciex). The Graph Pad Prism software version 5 was used for all statistical calculations related to quantitative analysis.
+ Open protocol
+ Expand
2

Quantitative Analysis of Cordycepin in GRC-SC11

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of cordycepin in GRC-SC11 was determined by UPLC quantitative analysis, as described previously [8 (link)]. UPLC-Q-TOF-MS analysis was performed using a Waters Acquity UPLCTM system (Waters Corp., Milford, MA, USA) equipped with a Waters Acquity BEH C18 column (100 mm × 2.1 mm × 1.7 μm particle size; Waters Corp.) and Waters Q-TOF Premier (Micromass MS Technologies, Manchester, UK). The UPLC-Q-TOF-MS analysis was performed following previously described methods [8 (link)].
+ Open protocol
+ Expand
3

Metabolomics Analysis of Bioactive Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The obtained sample from the bioautographic assay,
MS analysis, was coupled to identify the active metabolite based on
their molecular mass as obtained from spectral data. The MS was performed
on a Water’s ACQUITY UPLC (TM) system (Waters Corp., MA, USA)
equipped with a binary solvent delivery system, an auto-sampler, column
manager, and a tunable MS detector operated through Empower software
(Waters, Manchester, UK). For optimum chromatographic separation,
acetonitrile (A) and water (B) were run on a monolithic capillary
silica-based C18 column (ACQUITY UPLC(R) BEH C18 1.7 μm, 2.1
× 100 mm). The flow rate of the nebulizer gas was set at 500
L/h; for cone gas, it was set at 50 L/h, and the source temperature
was fixed at 100 °C. The capillary and cone voltage was set at
3.0 and 40 KV, respectively. For collision, argon was employed at
a pressure of 5.3 × 10–5 torr. The obtained
spectral data from MS was processed by Mass Lynx V4.1 (Waters, USA)
and further used for metabolomics analysis of the samples. Separated
metabolites present in different samples were tentatively identified
based on their m/z values from mass data sources
such as Mass Bank, PubChem, Drug Bank, ChemSpider, and literature.47 (link),49 (link)
+ Open protocol
+ Expand
4

Quantification of Tofacitinib in Plasma by UPLC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were immediately transferred to K2 EDTA tubes. Plasma was separated by centrifugation at 3,000 rpm for 10 minutes at ≤ 4˚C and stored below −70˚C until analysis.
The plasma concentration of tofacitinib was determined by ultra-performance liquid chromatography (UPLC, Waters ACQUITY UPLCTM System, Waters Co., Milford, MA, USA)-tandem mass spectrometry (MS/MS, Waters XevoTM TQ MS, Waters Co.). Stock standard solution (100 μg/mL of tofacitinib in 50% methanol) was used as a reference standard. The samples were analyzed on a Waters ACQUITY UPLC® BEH C18 column (1.7 μm, 2.1 mm ID × 50 mm L; Waters Co.) using acetonitrile and 0.1% ammonium acetate in distilled water (80:20, v/v) as the mobile phase within 0.4 mL/min.
This method was validated over the concentration range of 0.5–250 ng/mL for tofacitinib. The lower limit of quantitation (LLOQ) was 0.5 ng/mL. The intra- and inter-batch precision (coefficient of variance [CV]) and accuracy ranged from 1.6–6.4 and 97.9–103.0%, respectively. All validation results were in compliance with the EMA Guideline on Bioanalytical Method Validation [16 (link)].
+ Open protocol
+ Expand
5

UPLC-MS Analysis of Chemical Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LC-MS was performed on Water’s ACQUITY UPLCTM system (Serial No # F09 UPB 920 M; Model code # UPB; Waters Corp., Milford, MA) equipped with a binary solvent delivery system, an auto sampler, column manager, and a tunable MS detector (Serial No # JAA 272; Synapt; Waters, Manchester, UK). Chromatographic separation was performed on a Water’s ACQUITY UPLCTM BEH C18 (100.0 × 2.1 mm ×1.7 μm) column at 40 ± 5 °C. The mobile phase used for UPLC analysis consisted of 0.5% formic acid (A) and acetonitrile (B), at a pH of 2.7, which was degassed before analysis, and the gradient elution was 2 to 100% (B) in 40 min at a flow rate of 0.5 mL/min and 25 °C. The injection volume was 20 μL. The column and auto sampler were maintained at 40 ± 5 °C and 25 ± 5 °C, respectively, and the pressure of the system was set to 15000 psi.
+ Open protocol
+ Expand
6

UPLC-MS Analysis of BMAE Constituents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The freeze dried powdered of BMAE was dissolved in LCMS grade acetonitrile and water (100 µg mL-1) and filtered. The constituents were analyzed on a Water’s ACQUITY UPLCTM system (Serial No# F09 UPB 920M; Model Code# UPB; Waters Corp., MA, USA) equipped with a binary solvent delivery system, an auto-sampler, column manager and a tunable MS detector (Serial No# JAA 272; SYNAPT; WATERS, Manchester, UK). Chromatographic separation was performed on a Water’s ACQUITY UPLCTM BEH C18 (100.0 mm x 2.1 mm; 1.7 µm) column at 40 ± 5 °C. The UPLC analysis was done using water: acetonitrile (90:10; v/v), as solvent system in gradient elution. The flow rate of the mobile phase was kept at 0.35 mL min-1 and 10 µL of sample solution was injected in each run. The total chromatographic run time was 30 min. The column and auto-sampler were maintained at 40 ± 5 and 25 ± 5 °C, respectively whereas the pressure of the system was set to 15000 psi.
+ Open protocol
+ Expand
7

UHPLC-MS Metabolite Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Waters ACQUITY UPLCTM system from Waters Corp., MA, USA, hyphenated with a binary system of solvent delivery and tuneable MS detector (Synapt; Waters, Manchester, UK), was used to perform the process of UHPLC whereas Waters ACQUITY UPLCTM BEH C-18 column with dimension, i.e. 2.1 mm × 100 mm, 1.7 µm was utilized for chromatographic separation. The UHPLC mobile phase conditions were as follows: degassed LC-MS grade solvent, i.e. Acetonitrile (85 %): 10 mM Ammonium Formate (15 %): Formic Acid (0.1 %), v/v/v, with isocratic elution, flow rate of 0.25 mL/min sample injection volume of 10 µl/run and a total chromatographic run time of 5.0 min.
+ Open protocol
+ Expand
8

Optimized UPLC-MS Bioanalytical Method

Check if the same lab product or an alternative is used in the 5 most similar protocols
For chromatographic separation, the system and tool used with specifications consisted of Waters ACQUITY UPLC TM system (Waters Corp., Milford, MA); a binary solvent delivery system with an attached autosampler and tunable MS detector (Synapt MS; Waters Corp., Manchester, UK) and Waters ACQUITY UPLCTM BEH C-18 column (2.1 Â 100 mm; 1.7 lm). Whereas the gradient system used for mobile phase consisted of 70% (acetonitrile): 30% (2 mM ammonium formate): 0.01% (formic acid) v/v/v, flow rate ¼ 0.25 ml/min and an injection volume of 10 lL. For the validation of developed bioanalytical method, the 64 guidelines were applied, whereas for best fit relationship and for the concentration-detector response [46] , regression equation (weighting factor for IS concentration i.e. 1/x 2 ) was applied.
+ Open protocol
+ Expand
9

UPLC-MS/MS Quantification of NBP

Check if the same lab product or an alternative is used in the 5 most similar protocols
NBP was obtained from Shijiazhuang Pharma Group NBP Pharmaceutical Co. Ltd., Shijiazhuang, Hebei Province, China. DL-o-chlorophenylalanine, used as internal standard (IS), was purchased from GL Biochem (Shanghai) Ltd. Acetonitrile, methanol and ultra-pure water were of chromatographic grade and obtained from Merck Company, Darmstadt, Germany. Formic acid was purchased from CNW, Shanghai, China. The Waters AcquityTM UPLC system was coupled with the Waters XevoTM Q-TOF mass analyzer. The column used for this analysis was the Waters Acquity UPLC HSS T3 column (2.1 mm×100 mm, 1.8 μm), Waters Company, America.
+ Open protocol
+ Expand
10

UPLC-MS/MS Analysis of Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chromatographic analysis was conducted on Waters AcquityTM UPLC System, and a Waters AcquityTM UPLC HSS T3 (2.1 mm × 100 mm, 1.8 μm) (Waters Corp., Milford, MA, USA) chromatography column was used at a temperature of 50 °C and a flow rate of 0.4 mL/min. The injection sample volume was 5 μL. The mobile phase consisted of 0.1% formic acid in acetonitrile (solvent A) and 0.1% formic acid in water (solvent B), and the gradient eluting conditions were as follows: 0–2 min, 5–13% A; 2–11 min, 13–25% A; 11–18 min, 25–45% A; 18–20 min, 45–70% A;20–23 min, 70–100% A.
The Waters SynaptTM G2-Si MSE mass spectrometry system (Waters Corporation, Milford, MA, USA) was used to collect data in both positive and negative ion modes (ESI+, ESI−). The optimized conditions were as follows: ion source temperature 110 °C, desolvation gas temperature 350 °C, cone gas flow rate 50 L/h. In positive ion detection mode, the capillary voltage was 2.8 kV, the sample cone voltage was 20 V, the extraction cone voltage was 4.0 V, and the desolvation gas flow rate 800 L/h. In the negative ion detection mode, the capillary voltage was 2.2 kV, the sample cone voltage was 40 V, the extraction cone voltage was 4.0 V, and the desolvation gas flow was 600 L/h. Leucine enkephalin solution was used as the mass lock solution. The data acquisition interval was 0.2 s/scan, and the mass scanning range was 50–1200 Da.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!